Team:Paris/August 13

From 2008.igem.org

(Difference between revisions)
Line 130: Line 130:
|'''Biobricks'''
|'''Biobricks'''
|'''Description'''
|'''Description'''
-
|-   
+
|- style="text-align: center;"
-
 
+
|S146.1
-
 
+
|L100.1
 +
| rowspan="3"| rbs TetR - ECFP<br>D110 (BV) -  D130 (BI)
 +
| rowspan="3"| [[Image:Part_icon_rbs.png]][[Image:Icon_coding.png]][[Image:Part_icon_rbs.png]][[Image:Part_icon_reporter.png]][[Image:Part_icon_terminator.png]]
 +
|- style="text-align: center;"
 +
|S146.2
 +
|L100.2
 +
|- style="text-align: center;"
 +
|S146.3
 +
|L100.3
 +
|- style="text-align: center;"
 +
|S147.1
 +
|L101.1
 +
| rowspan="3"| rbs TetR - GFP tripart<br>D110 (BV) -  D131 (BI)
 +
| rowspan="3"| [[Image:Part_icon_rbs.png]][[Image:Icon_coding.png]][[Image:Part_icon_rbs.png]][[Image:Part_icon_reporter.png]][[Image:Part_icon_terminator.png]]
 +
|- style="text-align: center;"
 +
|S147.2
 +
|L101.2
 +
|- style="text-align: center;"
 +
|S147.3
 +
|L101.3
 +
|- style="text-align: center;"
 +
|S148.1
 +
|L114.1
 +
| rowspan="3"| AracpBAD - gfp tripart<br>D126 (BV) - D131 (BI)
 +
| rowspan="3"| [[Image:Part_icon_regulatory.png]][[Image:Part_icon_reporter.png]]
 +
|- style="text-align: center;"
 +
|S148.2
 +
|L114.2
 +
|- style="text-align: center;"
 +
|S148.3
 +
|L114.3
 +
|- style="text-align: center;"
 +
|S149.1
 +
|L120.1
 +
| rowspan="3"| tetR repressible promoter - ECFP<br>D106 (BV) - D130 (BI)
 +
| rowspan="3"| [[Image:Part_icon_regulatory.png]][[Image:Part_icon_rbs.png]][[Image:Part_icon_reporter.png]][[Image:Part_icon_terminator.png]]
 +
|- style="text-align: center;"
 +
|S149.2
 +
|L120.2
 +
|- style="text-align: center;"
 +
|S149.3
 +
|L120.3
 +
|- style="text-align: center;"|
 +
|S150.1
 +
|L122.1
 +
| RBS-lasI - ECFP <br>D107 (BV) - D130 (BI)
 +
| [[Image:Part_icon_rbs.png]][[Image:Icon_coding.png]][[Image:Part_icon_rbs.png]][[Image:Part_icon_reporter.png]][[Image:Part_icon_terminator.png]]
 +
|- style="text-align: center;"
 +
|S151.1
 +
|L123.1
 +
| rowspan="3"| RBS lasI - ECFP<br>D107 (BV) - D131 (BI)
 +
| rowspan="3"| [[Image:Part_icon_rbs.png]][[Image:Icon_coding.png]][[Image:Part_icon_reporter.png]][[Image:Part_icon_terminator.png]]
 +
|- style="text-align: center;"
 +
|S152.2
 +
|L123.2
 +
|- style="text-align: center;"
 +
|S152.3
 +
|L123.3
 +
|- style="text-align: center;"
 +
|S152.1
 +
|L126.1
 +
| rowspan="3"| Strongest RBS (1)- LasR activator (+LVA)<br>D102 (BV) - D114 (BI)
 +
| rowspan="3"|[[Image:Part_icon_rbs.png]][[Image:Icon_coding.png]]
|}
|}

Revision as of 15:04, 13 August 2008

← Yesterday

↓ Calendar ↑

Tomorrow →


Minipreps: Plasmid extraction

  • Protocol (see # 3) Experiments done by QIAcube
  • List of Minipreps
Name Ligation Biobricks Description
MP147.1 L100.1 rbs TetR - ECFP
D110 (BV) - D130 (BI) 		Part icon rbs.pngIcon coding.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.png
MP147.2 L100.2
MP147.3 L100.3
MP148.1 L101.1 rbs TetR - GFP tripart
D110 (BV) - D131 (BI) 		Part icon rbs.pngIcon coding.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.png
MP148.2 L101.2
MP148.3 L101.3
MP149.1 L114.1 AracpBAD - gfp tripart
D126 (BV) - D131 (BI) 		Part icon regulatory.pngPart icon reporter.png
MP149.2 L114.2
MP149.3 L114.3
MP150.1 L120.1 tetR repressible promoter - ECFP
D106 (BV) - D130 (BI) 		Part icon regulatory.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.png
MP150.2 L120.2
MP150.3 L120.3
MP151.1 L122.1 RBS-lasI - ECFP
D107 (BV) - D130 (BI) 		Part icon rbs.pngIcon coding.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.png
MP152.1 L123.1 RBS lasI - ECFP
D107 (BV) - D131 (BI) 		Part icon rbs.pngIcon coding.pngPart icon reporter.pngPart icon terminator.png
MP151.2 L123.2
MP152.3 L123.3
MP153.1 L126.1 Strongest RBS (1)- LasR activator (+LVA)
D102 (BV) - D114 (BI) 		Part icon rbs.pngIcon coding.png
MP153.2 L126.2
MP153.3 L126.3
MP154.1 L132.1
MP154.2 L132.2
MP154.3 L132.3
MP155.1 L133.1
MP156.1 L134.1
MP156.2 L134.2
MP156.3 L134.3
MP157.1 L138.1

Glycerol Stocks

  • List of Stocks
Strain Ligation Biobricks Description
S146.1 L100.1 rbs TetR - ECFP
D110 (BV) - D130 (BI) 		Part icon rbs.pngIcon coding.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.png
S146.2 L100.2
S146.3 L100.3
S147.1 L101.1 rbs TetR - GFP tripart
D110 (BV) - D131 (BI) 		Part icon rbs.pngIcon coding.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.png
S147.2 L101.2
S147.3 L101.3
S148.1 L114.1 AracpBAD - gfp tripart
D126 (BV) - D131 (BI) 		Part icon regulatory.pngPart icon reporter.png
S148.2 L114.2
S148.3 L114.3
S149.1 L120.1 tetR repressible promoter - ECFP
D106 (BV) - D130 (BI) 		Part icon regulatory.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.png
S149.2 L120.2
S149.3 L120.3
S150.1 L122.1 RBS-lasI - ECFP
D107 (BV) - D130 (BI) 		Part icon rbs.pngIcon coding.pngPart icon rbs.pngPart icon reporter.pngPart icon terminator.png
S151.1 L123.1 RBS lasI - ECFP
D107 (BV) - D131 (BI) 		Part icon rbs.pngIcon coding.pngPart icon reporter.pngPart icon terminator.png
S152.2 L123.2
S152.3 L123.3
S152.1 L126.1 Strongest RBS (1)- LasR activator (+LVA)
D102 (BV) - D114 (BI) 		Part icon rbs.pngIcon coding.png
Retrieved from "http://2008.igem.org/Team:Paris/August_13"